- SpO₂ target 88–92%. Too much O₂ → more CO₂ retention.
- Albuterol + ipratropium nebs, prednisone 40 mg × 5 days.
- Antibiotics if more sputum purulence + more dyspnea or volume, or if on NIV/ventilator.
- BiPAP if pH <7.35 and PaCO₂ >45 — it saves lives and avoids intubation.
- Rule out the mimics: PE, HF, pneumonia, pneumothorax, ACS.
- Discharge: long-acting inhalers, pulmonary rehab within 4 weeks, smoking cessation, vaccines.
Pathophysiology in 60 seconds
⌄
- Trigger (virus ~50%, bacteria, pollution) → more airway inflammation, mucus and bronchospasm.
- Air trapping (dynamic hyperinflation): the patient cannot breathe out fully before the next breath → flat diaphragm, high work of breathing → fatigue → CO₂ rises.
- O₂ excess worsens hypercapnia by V/Q mismatch (loss of hypoxic vasoconstriction) and the Haldane effect — not mainly "loss of drive."
Diagnosis
⌄
- Exacerbation (GOLD/Rome): dyspnea and/or cough-sputum worse within ≤14 days.
- Severity (Rome): mild / moderate / severe by RR, HR, SpO₂, CRP, and ABG (PaCO₂, pH).
- Workup: VBG/ABG, CXR, ECG, CBC (eosinophils), BMP, BNP/troponin if cardiac doubt, viral PCR; CTPA if PE suspected (PE is found in ~1 in 6 unexplained exacerbations).
Management
⌄
1Hypercapnic acidosis (pH <7.35, PaCO₂ >45)?
Yes → BiPAP: IPAP 10–12 / EPAP 5; ABG in 1–2 h. Worsening, can't protect airway → intubate.
No ↓ O₂ to 88–92% (Venturi mask or nasal cannula).
▼
2Bronchodilators
Yes → Albuterol 2.5 mg + ipratropium 0.5 mg neb q4–6 h (albuterol q1–2 h as needed early).
▼
3Steroids
Yes → Prednisone 40 mg PO daily × 5 days (IV only if cannot take PO).
▼
4Antibiotics?
Yes → Purulent sputum + 1 other cardinal symptom, or on NIV/MV → 5 days.
| Antibiotic choice | When |
|---|---|
| Azithromycin 500 mg day 1 → 250 mg × 4 d | Uncomplicated |
| Doxycycline 100 mg BID | Uncomplicated |
| Amoxicillin-clavulanate 875 mg BID | Older, frequent exacerbations, FEV₁ <50% |
| Levofloxacin 750 mg / cefepime / pip-tazo | Pseudomonas risk (bronchiectasis, prior isolate, frequent abx) |
Eosinophils ≥300 predict steroid and ICS response. Low eosinophils → lower steroid benefit.
Discharge bundle
⌄
- ☐ Inhaler technique checked; LAMA + LABA; add ICS if eosinophils ≥300, or ≥100 with frequent exacerbations (avoid ICS with recurrent pneumonia)
- ☐ Biologic referral (dupilumab/mepolizumab) if eos ≥300 and exacerbations despite triple therapy
- ☐ Pulmonary rehab within 4 weeks
- ☐ Smoking cessation (varenicline/NRT); vaccines (influenza, COVID, pneumococcal, RSV ≥60, Tdap)
- ☐ Home O₂ evaluation (resting SpO₂ ≤88% or PaO₂ ≤55)
- ☐ Follow-up within 1–4 weeks; action plan
Pitfalls
⌄
- 100% non-rebreather in a CO₂ retainer.
- Missing PE or HF as the real cause.
- 14-day steroid tapers (no benefit over 5 days).
- BiPAP delaying needed intubation.
Board corner
⌄
| Stem | Answer |
|---|---|
| pH 7.28, PaCO₂ 68, alert | BiPAP |
| pH 7.15, drowsy, vomiting | Intubate |
| Exacerbation, purulent sputum, more dyspnea | Antibiotics + steroids |
| Best long-term survival interventions | Smoking cessation, O₂ (if hypoxemic), (LVR/transplant selected) |
| Steroid duration | 5 days (REDUCE) |
References
⌄
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 Report.
- Rochwerg B, et al. ERS/ATS NIV guideline. Eur Respir J. 2017;50:1602426.
- Leuppi JD, et al. REDUCE. JAMA. 2013;309:2223.
- Celli BR, et al. Rome proposal for exacerbations. AJRCCM. 2021.